Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi

Journal of Clinical Microbiology

Volumn 35, Issue 1, 1997, Pages 139-143

  Espinel Ingroff, A ^a   Bartlett, M ^b   Bowden, R ^c   Chin, N X ^d   Cooper Jr , C ^e   Fothergill, A ^f   McGinnis, M R ^e   Menezes, P ^c   Messer, S A ^g   Nelson, P W ^h   Odds, F C ⁱ   Pasarell, L ^e   Peter, J ^j   Pfaller, M A ^g   Rex, J H ^h   Rinaldi, M G ^f   Shankland, G S ^k   Walsh, T J ^j   Weitzman, I ^d  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d New York Presbyterian Hospital Columbia University Medical Center   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

ⁱ JANSSEN RESEARCH FOUNDATION   (Belgium)

^j NATIONAL CANCER INSTITUTE   (United States)

^k Reg Mycology Reference Laboratory   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASCOMYCETES; ASPERGILLUS; COLONY FORMING UNIT; COLORIMETRY; CONTROLLED STUDY; DRUG SENSITIVITY; FUNGUS; FUSARIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RHIZOPUS; STANDARDIZATION;

ASCOMYCOTA; ASPERGILLUS; FUNGI; FUSARIUM; PSEUDALLESCHERIA BOYDII; RHIZOPUS; RHIZOPUS ORYZAE;

EID: 0031059950     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.1.139-143.1997     Document Type: Article

References (20)

1. Anaissie, E. J., R. Hachem, C. Legrand, P. Legenne, P. Nelson, and G. P. Bodey. 1992. Lack of activity of amphotericin B in systemic murine fusarial infection. J. Infect. Dis. 165:1155-1157.
2. Beck-Sagué, C. M., W. R. Jarvis, and the National Nosocomial Infections Surveillance System. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167:1247-1251.
3. Denning, D. W., J. Y. Lee, J. S. Hosteller, P. Pappas, C. A. Kauffman, D. H. Dewsnup, J. N. Galgiani, J. R. Graybill, A. M. Sugar, A. Catanzaro, H. Galli, J. R. Perfect, B. Dockery, W. E. Dismukes, and D. A. Stevens. 1994 NIAID mycoses study group multicenler trial of oral itraconazole therapy of invasive aspergillosis. Am. J. Med. 97:135-144.
4. Espinel-Ingroff, A. 1995. Evaluation of different inoculum densities, incubation periods, and MIC endpoint determination methods for antifungal susceptibility testing of filamentous fungi, abstr. F-99. p. 104. In Abstracts of the 95th General Meeting of the American Society for Microbiology 1995. American Society for Microbiology, Washington, D.C.
5. Espinel-Ingroff, A., and T. M. Kerkering. 1991. Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi. J. Clin. Microbiol. 29:393-394.
6. Espinel-Ingroff, A., C. W. Kish, Jr., T. M. Kerkering, R. A. Fromtling, K. Bartizal, J. N. Galgiani, K. Villareal, M. A. Pfaller, T. Gerarden, M. G. Rinaldi, and A. Fothergill. 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30:3138-3145.
7. Espinel-Ingroff, A., K. Dawson, M. Pfaller, E. Anaissie, B. Breslin, D. Dixon, A. Fothergill, J. Peter, M. Rinaldi, and T. Walsh. 1995. Comparative and collaborative evaluation of standardization antifungal susceptibility testing for filamentous fungi. Antimicrob. Agents Chemother. 39:314-319.
8. Espinel-Ingroff, A., and M. A. Pfaller. 1995. Antifungal agents and susceptibility testing, p. 1405-1421. In P. K. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
9. Fothergill, A. (University of Texas at San Antonio). 1996. Personal communication.
10. Fromtling, R. A., J. N. Galgiani, M. A. Pfaller, A. Espinel-Ingroff, K. F. Bartizal, M. S. Bartlett, B. A. Body. C. Frey. G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993. Multicenter evaluation of a macrohroth antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
11. Gonzalez, C. E., K. Kligys, D. Shetty, R. Torres, W. Love, J. Peter, C. A. Lyman, and T. J. Walsh. 1996. Characterization of host defenses against Pseuitallescheria boydii: an emerging opportunistic pathogen, abstr. F-20. p. 77. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology. Washington. D.C.
12. National Committee for Clinical Laboratory Standards. 1995. Reference method tor broth dilution antifungal susceptibility testing of yeasts. Tentative standard M27-T. National Committee for Clinical Laboratory Standards. Villanova, Pa.
13. Pfaller, M. A., M. Bale, B. Buschelman, M. Lancaster. A. Espinel-Ingroff, J. H. Rex, M. G. Rinaldi. C. R. Cooper, and M. R. McGinnis. 1995. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilulion testing of amphotericin B. fluconazole. and flucytosine. J. CHn. Microbiol. 33:1104-1107.
14. Rex, J. H., C. R. Cooper, Jr., W. G. Merz, J. N. Galgiani, and E. J. Anaissie. 1995. Detection of amphotericin B-resistant Candida species in a broth-based system. Antimicrob. Agents Chemother. 39:906-909.
15. Rex, J. H., M. A. Pfaller, M. Lancaster. F. C. Odds, A. Bolmström, and M. G. Rinaldi. 1996. Quality control guidelines for National Committee tor Clinical Laboratory Standards-recommended broth macrodilution testing of ketoconazole and itraconazole. J. Clin. Microhiol. 34:816-817.
16. Rodriguez-Tudela. J. L., and J. V. Martinez-Suarez. 1994. Improved medium for fluconazole susceptibility testing ol'Candida alhicam. Antimicrob. Agents Chemother. 38:45-48.
17. Supparatpinyo, K., K. E. Nelson, W. G. Merz, B. J. Breslin. C. R. Cooper, Jr., C. Kamwan, and T. Sirisanthana. 1993. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicroh. Agents Chemother. 37:2407-2411.
18. Vartivarian, S. E., E. J. Anaissie, and G. P. Bodey. 1993. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and manaeement. Clin. Infect. Dis. 17(Suppl. 2):S487-S49I.
19. Walsh, T. J., J. Peter, U. A. McGough. A. W. Fothergill, M. G. Rinaldi, and P. A. Pizzo. 1995. Activity of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii. Antimicrob. Agents. Chemo-lhcr. 39:1361-1364.
20. Wingard. J. R. 1995. Importance of Candida species other than C. alhicum as pathogens in oncology patients. Clin. Infect. Dis. 20:115-125.